Peptide YY (PYY), a new peptide found primarily in mucosal endocrine cells of the terminal ileum and colon, inhibits pentagastrin-stimulated gastric acid secretion in several species, including man. Several studies indicate that PYY can affect autonomic neurotransmission, and we have recently shown that PYY can inhibit neurally stimulated release of insulin. The purpose of the present study was to examine the effect of PYY on gastric acid secretion stimulated by the autonomic nervous system. On separate days, 6 dogs that were prepared with chronic gastric cannulas were given 2-deoxy-D-glucose (2-DG; 90 mg/kg, i.v.) for 6 min, either alone, or in combination with PYY (100,200, or 400 pmol • kg–1 • h–1, i.v.) for 60 min. The effect of PYY, at 400 pmol • kg –1 • h–1, on gastric acid secretion stimulated by either 2-DG or PG (1 µg • kg–1 • h–1, i.v.) was studied after treatment with propranolol (0.5 mg/kg, i.v. bolus) or phentolamine 1 mg/kg, i.v. bolus). PYY reduced the 2-DG-stimulated secretion of gastric acid in a dose-dependent manner. PYY, given at 100 pmol • kg–1 • h–1, reduced gastric acid output by 29 ± 17%; PYY, at 200, by 41 ± 7% (p < 0.05, and PYY, at 400, by 52 ± 8% (p < 0.05). The inhibitory action of PYY on 2-DG-stimulated secretion of gastric acid persisted after treatment with phentolamine (69 ± 14 %; p < 0.05), but it was blocked by treatment with propranolol. By contrast, the inhibitory action of PYY on pentagastrin-stimulated secretion of gastric acid persisted after treatment with either phentolamine (40 ± 6%; p < 0.05) or propranolol (51 ± 4%; p < 0.05). This study shows that PYY, given at a physiologic dose, can inhibit gastric acid secretion stimulated by the autonomic nervous system. This effect of PYY can be selectively prevented by β-adrenergic blockade. Our findings suggest a role for PYY in the autonomic regulation of gastric acid secretion.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.